Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Asterand To Acquire BioSeek | Contract Pharma
Breaking News

Asterand To Acquire BioSeek

Asterand has signed an agreement to acquire BioSeek Inc., a drug discovery services company, for $1.0 million payable in Asterand shares.

Asterand has signed an agreement to acquire BioSeek Inc., a drug discovery services company, for $1.0 million payable in Asterand shares. The acquisition is part of Asterand’s strategy to enhance its position in the global human tissue services market, and according to a company statement, will be Asterand’s first step in its “buy and build” strategy.

A further payment of as much as $13 million will be payable in 2011, pending sales growth achieved by BioSeek by December 31, 2010. If further payment is made, the first $3.0 million will be paid in Asterand shares and additional payments will be either cash or shares.

BioSeek has developed a human primary cell based, high throughput assay system (BioMAP) designed to replicate the intricate cell and pathway interactions present in inflammatory, autoimmune and cardiovascular diseases. The system predicts clinical activities of a potential drug candidate through comparison of results to a database of profiles for known compounds.

BioSeek is located in South San Francisco, CA and has 14 employees. BioSeek’s key managers will join Asterand’s senior management team. Additionally, BioSeek’s chief executive officer, Dr. Mike Venuti, has agreed to act as a consultant to Asterand for a transition period.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters